Post by
NearlyDone on Sep 15, 2016 6:57pm
Follow the bouncing MCNA ball
I think I read a good post here a few weeks ago that suggeted maybe the smart move is to follow MCNA after this sale to PLI. But maybe MCNA won't even make it to PLI. Now that it is deemed a worthless asset maybe the company can just give it away like a broken down tractor. I was seriously surprised to find out a couple of weeks ago that Immocidin <the dog cancer version of MCNA> somehow wound up in the hands of the old CEOs company. How the heck did that happen and did we get compensated for it? But maybe it was just valued at zero before the sale of animal division and tossed away or maybe the French buyer of animal division sold it to him. It seemed to work on female dogs with cancer. It would not surprise me very much if MCNA is quickly moved out of PLI's hands, if it ever even makes it there in the transaction. I will be interested in following where it goes, especially now that it is a worthless asset, so we are being convinced of.